SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000929638-09-000747
Filing Date
2009-04-28
Accepted
2009-04-27 18:17:31
Documents
1
Group Members
BAM MANAGEMENT, LLCBAM OPPORTUNITY FUND, L.P.HAL MINTZROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 aantigenics13ga042709.htm SC 13G/A 178565
  Complete submission text file 0000929638-09-000747.txt   180515
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
ANTIGENICS INC /DE/ (Subject) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60419 | Film No.: 09773638
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-692-6340
BAM Capital, LLC (Filed by) CIK: 0001355197 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A